Making the choice: RP, homograft, mechanical, tissue

Valve Replacement Forums

Help Support Valve Replacement Forums:

This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
Valve Type

Valve Type

:)

Peter ... thanks so much for sharing all this information with us. I had my AVR done 4-10-00 and had virtually no time for proper research. My stenosis was so advanced that I was at great risk for sudden death even while I was making the impossible decisions of valve type, doctors, hospitals, etc.

Somehow I ended up choosing a Homograft Valve, and my surgeon was the Best-of-the-Best (of that I'm absolutely certain). I have often wondered if I would have chosen the Homograft had I had several months to look into everything. I only knew that I didn't want to be on coumadin.

As it turns out, I've breezed thru recovery and am feeling great 15 months post-op. It's very encouraging to see articles (and letters from Dr.s) leaning toward tissue valves and specifically homografts. At the age of 53, I'm certain to face a re-op along the way. Luckily, that's something I am at peace with -- especially considering all the wonderful medical advances on the horizon.

Best of Luck on your decisions, and please keep us posted as you go along. Before you know it, it'll all be behind you, and you'll be moving on to another chapter of your life.

Thanks again for sharing ~
 
Hey Peter

You really are breaking new ground here in sharing with us the correspondences with your doctors.

It really seems that your doctors are giving you some fairly "solid" advice, blunt and to the point even. Much better than a wishy-washy, fence-sitting approach. And, as you discovered, the medical profession does not have a consistent view.

I would think that your choice is now to do what the surgeon recommends or else consult another surgeon. I would be very wary about asking a surgeon (or any doctor for that matter) to do something against their own recommendation.

Peter, I know this must be a stressful time for you. However, let me tell you that once you get it behind you and after only a couple of weeks, you'll feel a million dollars. That should be your target - to get it behind you and feel like a million. In my case, I feel so well that if I felt any better, I'd be 2 people.

Remember, unfortunately, there is no "perfect" solution - only one with the least amount of hassles for "you". Whatever you decide will be right for you and you must go into this with a positive state of mind. Trust your cardiologist, trust your surgeon, trust your hospital and trust your decision. Make sure you are REALLY comfortable with your choice and you will get yourself a whole new life. And believe me, it's great this side of the mountain.

Congratulations on having started one of the most interesting and informative threads on this Forum to date - you can see from the responses how much personal information you have received.

Please keep us informed how you go in your decision.

Best wishes
 
Being two People

Being two People

I got a kick out of seeing your post saying something i say quite often. "If I were any better, there would have to be two of me."

And I agree that Peter's posts are some of the most interesting information to date.

Ben
 
Next surgeon interview

Next surgeon interview

I have my next interview with a surgeon on Monday, this time at Shands Hospital in Gainesville, Florida, with Dr. Tomas Martin, who performed AVR with the Cryolife Synergraft on Ben. Maybe then it will be time to "fish or cut bait," as they say -- and make the decision.

I'm struck by one thing in this overall search for the best answer and valve replacement option -- that is, the apparent best one for me. Whereas when buying a car or choosing a college with and for one's daughter, say, you have a sense of being able to get an objective rundown and comparison of the various options -- ironically, for a field that characterizes itself as a domain of science and expertise, that seems a lot more difficult when it comes to AVR, desipte it's life-shaking importance. It's more like fiefdoms, divided into camps with proponents of different approaches and crisscorssed by priviledged linkages between certain cardiologists and certain surgeons. Not that there's any ill will here, or any more than elsewhere in the universe (and probably a bit less, thanks to pretty widespread respect of the Hippocratic Oath), but the EFFECT on the patient is the same. That seems to be why the best advice I have received to date -- and a piece of advice I haven't entirely followed in my 360 degree investigation of alternatives -- is to find quite simply the best surgeon available of whatever stripe and then go with what he (no she's around?) counsels doing.

Well, it's an education.

Peter
 
Once more with feeling

Once more with feeling

Make that "Steve" [Wieland] in Gainesville, who has been very helpful and supportive. We have a Ben or two down here, too, including a veteran of the Ross Procedure at CCF, and I shouldn't try reproducing names so early on a weekend morning.

P.
 
Interesting article

Interesting article

This thread may be getting so ponderous it is better relegated to the mothball fleet. But I figure I'll continue posting things till my decision is made (which can't be much longer) in the interests of assembling a full account with helpful comments from others who have been there.

In that connection and just prior to my scheduled appointment with a surgeon at Shands Hospital in Gainesville tomorrow, Ken Dell sent the following excerpt from the July 2001 issue of the Journal of Thoraic and Cardiovascular Surgery, which I thought it worth posting.

://www.harcourthealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=fullfree&id=a115926


July 2001 ? Volume 122 ? Number 1




Editorials
In search of the ideal valve replacement device


John E. Mayer Jr, MD [MEDLINE LOOKUP]



Sections
References


Publishing and Reprint Information


See related article on page 129.


The search for an ideal cardiac valve replacement
began in the earliest days of cardiac surgery, and the
commandments describing the essential characteristics
of an ideal valve replacement device were outlined by
Dwight Harken1 in the 1950s. These characteristics
include durability, absence of thrombogenicity,
resistance to the ability to provide normal
hemodynamics, absence of damage to blood elements, and
technical practicality of insertion in a physiologic
position in the circulation. Additional desirable
characteristics include resistance to infection and
lack of immunogenicity. If valves are to be used in
children, the capacity for growth must be included as
well. Many prosthetic and bioprosthetic valves provide
good hemodynamic performance with low gradients and
insignificant regurgitation. However, no prosthetic
valve will be able to meet the nonthrombogenicity
criterion because a nonthrombogenic, blood-compatible
surface has not yet been developed. All prosthetic and
bioprosthetic valves remain more susceptible to
infection than native valves, a characteristic that is
related to the microfilms that cover most implanted
prosthetic surfaces. Native valves are living
structures that continuously remodel and repair their
structural proteins (collagen, elastin, and
glycosamino glycans), and because no current
bioprosthetic valves contain living cells, these
valves predictably have limited durability. Debate
continues over the value of living cells in a
homograft valve, but there is no evidence that
homograft valves have living interstitial cells that
can carry out the remodeling and repair functions of a
normal valve. The work in the accompanying article
demonstrates that both valve endothelial and
interstitial cells are capable of evoking an immune
response in vitro and support the concept that immune
factors may prove to be important to long-term
homograft function. Because no currently available
prosthetic, bioprosthetic, or homograft valve fulfills
all of these requirements, the search continues.


There is now increasing interest in trying to find
ways to create a truly living valve structure that
will have a nonthrombogenic endothelial surface and a
living interstitium with repair and remodeling
capabilities. Several groups, including our own, are
pursuing a tissue-engineering approach in which tissue
constructs are created from individual cellular
components by seeding cells onto biodegradable
scaffolds2 or a matrix of decellularized allograft
tissue.3 There have been some early favorable results
with these approaches in experimental animals,2,3 but
many questions remain, including the following. What
is the preferred scaffolding material on which to have
the cells organize, a biodegradable polymer or a
decellularized native valve matrix? What type of cells
should be used to populate the matrix, and must they
be autologous? Can progenitor or stem cells
circulating in the bloodstream repopulate an acellular
or decellularized matrix, or must the cells be
cultured onto scaffolds in vitro? Can these
tissue-engineered structures remain viable, sustain
the wear and tear of the normal circulation over a
lifetime, and grow in pediatric patients? Will human
cells cultured on scaffolds or a decellularized matrix
behave in the same way that cells from other mammalian
species behave? The answers to these and other
questions are actively being addressed and will help
to determine whether the tissue-engineering approach
will prove clinically applicable.


However, as we pursue the goal of an ideal valve
replacement, the stimulus of these attempts will also
be likely to lead to a better understanding of the
normal architecture and biology of cardiac valves and
of the abnormal developmental and pathologic processes
that affect them. The work in the accompanying article
is an important example of this stimulus and effect.
There is clearly a process at work in which pursuit of
a solution to a clinical need leads to renewed
interest in understanding more basic aspects of normal
and abnormal biology. This effect is similar to the
ways in which the development of the surgical
capability to address congenital heart disease in the
1940s and 1950s spurred renewed interest in the
pathologic anatomy of congenital heart disease. As a
surgical investigator in this era of the genetic
revolution, I hope that we will always remember the
importance of a 2-way flow of information and
intellectual stimulation between basic science and
clinical science. Neither can or should proceed
independently of the influence of the other.



References TOP


1. Harken DE. Heart valves: ten commandments and
still counting. Ann Thorac Surg. 1989;48:S18-9.
MEDLINE



2. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha
EA, Martin DP, et al. Functional living trileaflet
heart valves grown in vitro. Circulation.
2000;102(Suppl):III-44-9.


3. Steinhoff G, Stock U, Karim N, Mertsching H, Timke
A, Meliss RR, et al. Tissue engineering of pulmonary
heart valves on allograft acellular matrix conduits:
in vivo restoration of valve tissue. Circulation.
2000;102(Suppl):III-50-55.
 
Saw another surgeon

Saw another surgeon

Just back from a trip to Gainesville, FL (Shands Memorial Hospital) and an appointment with Dr. Tomas Martin, cardiac surgeon there who uses -- along with other AVR options -- the new Cryolife Synergraft approach. It was very interesting, and Dr. Martin proved to be a really pleasant and supportive person who spent better than 45 minutes with me going over options, despite the fact that my appointment had to be sandwiched in endwise, so to speak. In addition, I had the opportunity to have lunch just before with Steve Wieland, who has been on these threads and himself underwent (successfully) the Cyrolife SG procedure with Dr. Martin just two months ago. Steve gave me a LOT of helpful insight into the procedure and into the operative and post-operative experience. Nothing beats having been there.

I was also, the night before, able to talk by phone with Gary Rocco in Pittsburgh, who underwent AVR with Dr. Tony Cosgrove at CCF in Cleveland and opted for the Carpentier-Edwards Perimount pericardial (bovine) valve. Interestingly, both he and Steve were out of the hospital in about 4 days, though there were rigors in recovery that each of them has had to deal with -- and has dealt with successfully.

Dr. Martin explained what he sees as the prime causes and history of AS. Interestingly (see comments in the thread on hereditary character of disease) he says most AS worldwide is attributable to infant rheumatic fever, often just strep throat left to cure itself. He gave me a great rundown of the different AVR options and discussed what he sees as the pluses and minuses of each. Rather than firmly recommending any single approach, his tack is instead to say, "If you're most concerned by such-and-such a factor, go this way; if you're most concerned by such-another factor, you probably want to go that way."

For example, people most focused on cross-clamp dangers and the length of the operation -- i.e. those who want to get in and out quickly -- and/or those who want to maximize chances of avoiding reoperation and who, in addition, seem themselves as good and regular medecine takers probably should opt for the mechanical valve. People on the other hand who want to avoid Coumadin (and he says he himself is no Coumadin fan, given cumulative rates of thrombosis) and who don't mind looking at reoperation 15 years down the pike on average probably should jump for a stented porcine or bovine valve, as it is the simplest tissue alternative with the least scarring.

Those who want both to avoid Coumadin and to roll the dice for optimal chances of no re-operation (or length of time free of re-operation) should go with the stentless porcine alternatives, or more likely yet the homograft or Ross Procedure. He doesn't think RP gets much in the way of permanence over the newer homografts in return for a more complex operation, so tends to lean to the latter. The hope with the new Cryolife SG valve -- a homograft -- is that its tissue washing technology neutralizes the factors in homografts that trigger eventual immune reaction and calcification and allows the donor's body to repopulate the graft with its own cells. There are some indications that this works, but insufficient long-term data so far to be sure.

So you pays your money and takes your choice, I guess. In any case, I came away with a lot of useful info and "education" -- and very pleasantly impressed with Dr. Martin. Decision time looming for me this week. Best to all!

Peter
 
Hi Peter. So glad to see you had such an informative and pleasant meeting with Dr. Martin. Everything you relate fully resonates my experience with him. Also, with me, he never pushed a particular option, just presented the pros and cons of each as he viewed them. Actually, if my friend surgeon hadn't adjusted his original conservative approach to preferring the tried and true mechanical over the very new SynerGraft valve, I would probably be taking Coumadin as we speak!

However, reading that article you posted earlier from Ken Dell makes me really comfortable with my choice of the SynerGraft. That article is very convincing that, even if the SynerGraft fails to work as intended, it is certainly on the right and, for me, best track to the 'ideal' valve solution. Personally, I'll take real flesh over plastic and metal any day, especially now that I'm experiencing such good results (albeit short-term) from it. No doubt the mechanicals are really good now and getting better all the time and I don't think I would have gone wrong with it. But, the idea of having a valve that can not only repair and maintain itself but also grow if it needs to is truly revolutionary beyond anything else that I see out there. Indeed, my surgeon friend, after becoming better informed about the SynerGraft and talking to the surgeons most involved in its development, says that if this thing works as hoped for it would be a 'silver bullet' and they'll have to have a major war to supply enough valves for the demand! Too premature to worry about that, but I am now convinced that, whereas there is a limit to how much a mechanical valve can be improved because it is not living tissue, bioprosthetics, with the new developments taking place in genetic tissue engineering, actually have the potential to replace native valves as closely to a healthy original that's possible.

I was also very surprised by the strong endorsements from CCF for bioprosthetics for someone of your age. Indeed, at this moment, if I were to buy stock, I would invest in the future of bioprosthetics over mechanicals. Of course, I may drop dead tomorrow, and then all the rest of you will be the wiser! I guess we'll all just have to stay tuned and each of us make our own decisions as best we can when time no longer gives us the option of waiting for the definitive outcomes of all these issues.

In any case, best wishes and prayers for you, my new heart buddy, in making your choice in this matter. If you choose to go with Dr. Martin, I would be more than eager to help you and your family with logistics and whatever you need to get this done in Gainesville. Another heart buddy from this site, Mike, was extremely helpful to me in delivering printouts of posts from this site while I was in the hospital and keeping our other heart buddies hear informed of my situation. We would be delighted to do the same for you.

Thanks again for lunch and stay in touch.
 
Hey Peter,
I had an AVR in August '99 at the Mayo Clinic in Rochester. I chose a homograft and have been very happy with my choice. I was 45 years old at the time, and liked to ski and mountain bike. For me the coumadin was a major factor, and I accepted the fact I would most likely need repeat surgery in 15 years or so. It's a tough choice, and at different times I had decided on a mechanical, a Ross, and the homograft. I did lots of research and decided what was best for me with my lifestyle. I'm also from Florida, and was very happy with the Mayo Clinic, and glad I made the trip up there. Best of luck on your decision.
 
To Steve in Florida

To Steve in Florida

Hi Steve .. it's so fascinating to read the posts regarding the new Cryolife SG Valve. I'm so glad that you're feeling well and happy with that decision. I personally chose a homograph aortic valve and had my surgery 15 months ago in Houston. (I'm also doing very well and happy with my progress.)

I'm wondering if you or anyone can direct me to the best web site for this CryoLife SG valve. It's now really gotten my attention.... not that I plan on needing it in the next 15-20 years :) .

Anyway, I'm wanting to make up a notebook with articles on the most promising valve advances.... and this certainly seems to be one of those.

Thanks to you and Peter and everyone for sharing all this wonderful data with us. It's amazing how things have developed just in the last year. Can't imagine what wonderments we'll be looking at in 15-20 years.

Hope you continue with your uneventful recovery, and look forward to chatting with you now and then.

All the Best ~
 
Last edited:
Thanks Bill

Thanks Bill

Thanks Bill. Glad to hear you're doing so well also.

The most information about the CryoValve-SG is on its manufacturer's website (CryoLife). Also, do a general search for CryoLife, CryoValve, and SynerGraft. Of course, the best information I got was from my surgeon and his mentor, my surgeon friend, who has been in contact with the principal surgeon developers of the SynerGraft valve technology and who also attended the most recent (May) cardiothoracic surgeons conference where the results of two separate research studies on the SynerGraft valve, one with animals and the other humans, were presented.

Thanks again for your interest and encouragement. Now that I've been through the surgery, I believe that I would opt for a homograft even if it didn't hold out the promise to last the rest of my life like the SynerGraft valve does. Of course, my next surgery might not go as well and then I would think different. But, as it stands, I now consider resurgery less aversive than having to live with the inconvenience and risk of Coumadin.

But, then again, in 15-20 years, a lot will have changed.

Take care and I too am eager to continue to follow the developments in this area even though my choice is already set in--well, you know, flesh! Let's keep in touch.
 
To Peter Easton

To Peter Easton

One other remote possibility is the Homovital Valve, a live 'homograft' which appeared to be the longest lived tissue valve I found during my search.

Its availability in the United States is a mystery. I could find no one who would discuss it.

However, it is used with some frequency, I undertand, in homogenous countries where the gene pool is undiluted. If you want to pursue this option, along with the other work you are doing, the Surgeon who has done more with it and more writing about it is Dr.Yacoub, whom I tried fruitlessly to reach at his office in England.

Let me know if you want to explore this avenue and I'll try and find his phone number in my files. Basic information about it can be found via a search engine. It is elusive, however.
 
To Gary

To Gary

Is that the same thing, or virtually the same as, the old-style homografts in this country -- that is, the valves that had to be "harvested" from donors and implanted in reicipients within some short period like 24 or 48 hours? As I remember, my sister, who had her AVR 10 years ago, was hoping for one of those, but no donor turned up in the timeframe available, so she went with a porcine valve.

I gather that the Cryolife SG valve -- a homograft -- is intended to mimic or reproduce some of those benefits by elimination of the factors that lead to immune reaction and calcification.

Peter
 
Indeed, I just spoke again with my surgeon and he confirmed that within a year my new CryoValve-SG valve should histologically be indistinguishable from my native valve (or the way it should have been if two of its cusps hadn't been congenitally fused), that is, if it performs as it has in animal studies and in the few humans who had it implanted and have since been reopened for unrelated reasons.

He also gave me some other great news about this valve and my condition which I am reporting in response to BillC in the New Advancements Forum.

Hope all is going well with your decision-making process, Peter. You may be making one of the most informed choices of any of us so far.
 
Back to Steve

Back to Steve

Steve .. I didn't realize that the CryoLife S-G Valve was a homograph designed to last a life-time. This story just keeps getting better and better. Please keep us apprised of any more news or info you get on this. I'm going to find out what I can on the web-site. I'm also curious where (cities) these surgeries are being performed. Till later ~
 
More questions

More questions

Steve --

This recent exchange puts me in mind of a question that arose in my discussion with Dr. Martin at Shands and that I forgot to clarify. Am I correct that the Cryolife Synergraft valve that he implants for AVR is a pulmonary homograft, not an aortic one. He said something about other pulmonary homografts to the aortic position having a rather more rapid history of calcifying than alternate valves. The hope is that the Synergraft technology will overcome this by neutralizing or avoiding the immune response -- but if not, he seemed to be saying, then the jury is out as to how well the pulmonary transplant will do in the aortic position.

What's your take on this.

Also, for everyone's information, David on the Ross Procedure listserve passed along the web address of the proceedings of a recent London symposium on valve disease and replacement that is worth checking out:

http://www.shvd.org/doc/4333

Peter
 
Yes, Peter, the SynerGraft valve implanted in me by Dr. Martin was an altered pulmonary valve. I spoke to Dr. Martin about this yesterday and have related his explanation in a comment in the New Advancements forum on this website.

Although an ordinary pulmonary valve is thinner and therefore somewhat less strong and durable than an ordinary aortic valve, he said that studies have shown that, due to the SynerGraft treatment, the pulmonary valve is actually remodelled or transformed within a year into an aortic valve histologically the same as a native aortic valve. For instance, my own body cells should populate the implanted valve and adjust the thickness, etc., to whatever is needed in that position, since it is effectively a living valve rather than regular tissue valves whose cells have been chemically killed in order to prevent or reduce rejection, transferral of virsues, etc.

There is further explanation about the SynerGraft treatment process and the general cryopreservation process CryoLife uses on its website. Also, CryoLife presented several new studies at the recent conference in England that you provided a link to, referenced under tissue engineering #79.

I already knew that the SynerGraft valve I received was a pulmonary valve but didn't really understand why until BillC questioned it and I was able to get clarification from Dr. Martin.

I expect that CryoLife will probably be able to provide SynerGraft aortic valves for aortic valve replacement in the future, but I also get the impression that they are going more in the direction of using animal valves as the primary source, since if the technology really works as well as they expect the neutral collagen animal tissue will be transformed into a living aortic valve anyway and the supply of animal valves will be much more plentiful and less problematic than human valves if the demand greatly increases, which, by the way, some stock analysts are in fact predicting.

Hope this helps.
 
Decision half made

Decision half made

Hi folks --

Long as this thread is, it seems to me worthwhile to finish out the story, so to speak, before I move into the presurgery and then post-surgery forum!

Today I pretty much REACHED A DECISION regarding my own surgery -- though, true to form as a Gemini (and one who even SEES double, would you believe?), I left some waffle room.

I have decided to have the procedure done at Shands Hospital at the University of Florida under Dr. Tomas Martin -- but have left in abeyance until I talk to him once more whether it will be a Cryolife Synergraft valve (new style pulmonary homograft to the aortic position, hopefully able to repopulate with the recipient's own cells) or a Carpentier-Edwards Perimount pericardial version (bovine).

Dr. Martin said that he himself would hesitate between these two options and tried to lay out the pros and cons.

The CE Perimount bovine valve has apparently shown very good results in 15-20 years of trials, with a relatively high proportion of patients remaining re-operation free beyond 15 years. It is, I understand, stented and so easier to implant than stentless valves or homografts and doesn't require as long an operation as those alternatives or as much "cross-clamp" time (i.e., time on the heart/lung pump). But I gather that as a bovine valve, and thanks to its particular design, it still does not calcify as quickly as other stented valves often do. In addition, I think that calcification tends to be slower in semi-senior citizens like yours truly (59 anos) than in younger folks. And I feel at home with the likelihood, in this case, of re-operation 15 or 20 years hence -- when technology may have made some new leaps and bounds. But I might be wrong on any of these particulars and would welcome corrections.

As for the Cryolife SG homograft valve, it is intriguing and holds out the hope of near permanence. It's a little like rolling the dice, though happily even if they come up snake eyes -- that is, even if the cell repopulation wager doesn't pan out -- you're not so bad off, since the homograft would likely last around 12-15 years, I think, and you'd just be back in a scenario a little like the one above. The operation IS more complex than the CE Perimount implantation and requires significantly more cross-clamp time (Dr. Martin estimates 90-110 minutes as compared to 60 minutes or so for the bovine valve). Steve Wieland ("Steve in Florida") has given some GREAT descriptions and analyses of the Cryolife SG valve in his postings, particularly those on the "New Advancements" forum. Any one vaguely interested should take a long look there, I think.

I was never much enamored of the mechanical valve solution, I'll have to admit, due to dislike of Coumadin and concern about the chances of thrombosis (small per patient year but appreciable in the cumulative aggregate). Ticking doesn't bother me: I make worse sounds at the drop of a hat. But circulatory mishaps and the problems of balancing anti-coagulant levels in someone who loves his greens do. There's some bright light on this horizon, though, as well -- hand-held INR verification devices, improvements in the mechanical valves (AHS models: did I get those letters right?), and somewhere in the offing a less virulent alternative to warfarin.

I gave some serious early (and middle) consideration to the Ross Procedure, which is a fascinating approach with some excellent results and seems particularly full of hope for younger people who need the valve to grow with them and/or want a real chance of not undergoing multiple surgeries down the long pike before them. But it is a much lengthier operation (cross-clamp time in excess of 150 minutes, sometimes over 200, I gather), due to the need to replace two valve systems (the aortic and the pulmonary) at the same time. The chances it gives of avoiding reoperation over the life expectancy of someone my age seemed not that much greater than the first two alternatives above and the hemodynamic results appear comparable (i.e., smoothness of blood flow). So, on balance, it didn't seem the way to go, though I certainly cheer for those who opt for that route.

Of course, the decision is as much -- it is rightly argued -- one among surgeons and hospitals as it is a choice of a particular valve solution. Some say with justification, "Pick the best surgeon available and do what he (still no "she's"?) says." But what is the "best," in either regard? There are certainly very highly reputed surgeons and clinics, though some of the best clinics by national ratings can take on a bit of a factory flavor, to judge by occasional stories of patients and cardiologists.

And what weight should one give to proximity and the support that it enables family, friends and loved ones to provide? I gave some, though not enough to impel me to have the operation here in Tallahassee, where the very friendly surgeon does mechanical and Toronto SPV, but couldn't offer the particular choice I felt best for my case. Gainesville is about 150 miles away and in the territory of that Other State University, but still a very friendly place and one relatively nearby on a Florida scale of things.

I think that the surgeon and clinic issues should factor into the decision and should always be kept in mind, but they probably weigh most heavily in cases where there seem to be reasons to anticipate operative complications. I'm hoping for few and do perceive a slight degree of favorable surgeon bias toward a non-smoker small-drinker like myself still hanging in around 160 pounds dripping wet and having few other health problems: probably looks like something that might raise the surgical batting average!

So I've opted for Shands and either the bovine or the Cryolife SG solution -- to be finally resolved upon further consultation with the surgeon. Now the trick is to schedue the thing, because Dr. Martin is a busy person! In fact, when I called in today and heard that the calendar of surgery had (understandably) filled up further since I had my appontment with him there on Monday, I was put in mind of the song Judy Collins sang: "Just when I stopped, opening doors, finally knowing the one I wanted was yours, Making my entrance again with my usual flair, sure of my lines --- no one is there." (!)

But it may in fact work out for the best. I was startled when the Administrative Assistant said the earliest available slot was now early September, and I lobbied for getting somehow slid in sidewise during August, given the minuscule aperture left me (0.61 cm2 at last glance). But the main factor in my case, the cardiologist seems to feel, is my relative lack of symptoms. I can still walk up several flights of stairs with light loads and have had no dizziness or pain. I am wondering then whether a later date -- e.g. September 4th -- might not allow me the time to do something valuable for me and the procedure that I otherwise seldom do: take time off BEFORE, rest up, smell the roses, eat my greens and generally get in the right frame of soul and body.

Should know more about that tomorrow. Please excuse the length of this contribution, but I figured a long thread merited a longish coda.

Beneath all this, I feel immense gratitude and wonderment at life. And I think of all those folks a century or two ago who never had this second chance. But then, as my Grandma used to say, "Very few of us get out of this world alive!"

Peter
 
Peter, congratulations on making your decision. It has nothing to do with selection criteria, but I found it interesting that in the end the most popular and the rarest of the tissue alternatives made your cut.

I'm glad you came to a decision that you feel comfortable with.
Kev
 
Good for You

Good for You

Peter .. I know it's got to be a great relief to have made these decisions. The rest is easy compared to this.

Hope to continue to hear from you throughout your journey.

All the Best ~
 
Back
Top